Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

(PE)HRG214 reported well tolerated in HIV-infected patients

March 18, 2003

New HIV RT inhibitors identified by Boehringer Ingelheim researchers

March 18, 2003

FDA approves first fusion inhibitor for HIV infection

March 17, 2003

Urea-based HIV protease inhibitors identified by Pharmacor researchers

March 14, 2003

Good safety profile reported for PRO-2000 gel in HIV-infected and uninfected women

March 11, 2003

NIH licensing opportunity: anti-HIV agents targeting NCp7

March 10, 2003

MVA-BN nef shows promise in HIV trial

March 7, 2003

Calanolide A combination therapy for HIV completes clinical trial

March 6, 2003

IL-2 combined with HAART reported to enhance immune restoration in HIV infection

March 6, 2003

New CCR5 antagonists in Merck development pipeline

March 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...